Vice President, Development Innovations
Carol serves as the Vice President for Sarah Cannon Development Innovations and European Operations. Her responsibilities include overseeing Sarah Cannon's CRO, Development Innovations and shaping the company’s vision for global collaborations.
Woodward joined Sarah Cannon in 2016 and has more than 20 years of drug development experience in hematology and oncology research. She received her master’s degree from the University of Wales in England in 1999. Before joining Sarah Cannon Research Institute, she was the Vice President of Hematology/Oncology Global Project Management at PPD and prior to that worked on drug research and development at Shire Pharmaceuticals.